Regeneron Pharmaceuticals, Inc v. Novartis Pharma AG
| Regeneron Pharmaceuticals, Inc. |
| Novartis Pharma AG, Novartis Technology LLC, Novartis Pharmaceuticals Corporation and Vetter Pharma International GMBH |
| 22-427 |
| March 1, 2022 |
| U.S. Court of Appeals, Second Circuit |
| STATUTES-Antitrust |
Opinions
We have the following opinions for this case:
| Description |
|---|
 Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG
|
Docket Report
RSS Track this Docket
This docket was last retrieved on April 6, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 60 ATTORNEY, Lisa Pensabene for Novartis Technology LLC, Novartis Pharmaceuticals Corporation, and Novartis Pharma AG, in case 22-427, [ # 59 ], ADDED.[3292588] [22-427] [Entered: 04/06/2022 04:22 PM] |
| Filing 59 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC, FILED. Service date 04/06/2022 by CM/ECF. [3292497] [22-427] [Entered: 04/06/2022 03:07 PM] |
| Filing 58 ATTORNEY, Joshua Halpern for Regeneron Pharmaceuticals, Inc., in case 22-427, [ # 56 ], ADDED.[3286959] [22-427] [Entered: 03/29/2022 11:07 AM] |
| Filing 57 ATTORNEY, Anish R. Desai for Regeneron Pharmaceuticals, Inc., in case 22-427, [ # 53 ], ADDED.[3286957] [22-427] [Entered: 03/29/2022 11:06 AM] |
| Filing 56 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. Service date 03/29/2022 by CM/ECF. [3286956] [22-427] [Entered: 03/29/2022 11:06 AM] |
| Filing 55 ATTORNEY, Eric Shaun Hochstadt for Regeneron Pharmaceuticals, Inc., in case 22-427, [ # 52 ], ADDED.[3286953] [22-427] [Entered: 03/29/2022 11:05 AM] |
| Filing 54 ATTORNEY, Elizabeth Weiswasser for Regeneron Pharmaceuticals, Inc., in case 22-427, [ # 51 ], ADDED.[3286946] [22-427] [Entered: 03/29/2022 11:03 AM] |
| Filing 53 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. Service date 03/29/2022 by CM/ECF. [3286936] [22-427] [Entered: 03/29/2022 10:58 AM] |
| Filing 52 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. Service date 03/29/2022 by CM/ECF. [3286927] [22-427] [Entered: 03/29/2022 10:54 AM] |
| Filing 51 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. Service date 03/29/2022 by CM/ECF. [3286918] [22-427] [Entered: 03/29/2022 10:50 AM] |
| Filing 50 ATTORNEY, Stephen McIntyre for Novartis Technology LLC, Novartis Pharmaceuticals Corporation, and Novartis Pharma AG, in case 22-427, [ # 49 ], ADDED.[3283560] [22-427] [Entered: 03/23/2022 03:53 PM] |
| Filing 49 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Novartis Technology LLC, Novartis Pharmaceuticals Corporation and Novartis Pharma AG, FILED. Service date 03/23/2022 by CM/ECF. [3283483] [22-427] [Entered: 03/23/2022 03:05 PM] |
| Filing 47 SO-ORDERED SCHEDULING NOTIFICATION, setting Appellant Regeneron Pharmaceuticals, Inc. Brief due date as 06/10/2022. Joint Appendix due date as 06/10/2022, FILED.[3282565] [22-427] [Entered: 03/22/2022 02:56 PM] |
| Filing 43 MOTION ORDER, granting motion to remove appeal from Expedited Appeals Calendar [ # 37 ], filed by Appellant Regeneron Pharmaceuticals, Inc., by WJN, FILED. [3282424][43] [22-427] [Entered: 03/22/2022 12:56 PM] |
| Filing 40 ATTORNEY, Melissa Claire Cassel for Novartis Technology LLC, Novartis Pharmaceuticals Corporation, and Novartis Pharma AG, in case 22-427, [ # 39 ], ADDED.[3280513] [22-427] [Entered: 03/18/2022 12:24 PM] |
| Filing 39 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC, FILED. Service date 03/18/2022 by CM/ECF. [3280482] [22-427] [Entered: 03/18/2022 12:11 PM] |
| Filing 37 MOTION, to remove appeal from Expedited Appeals Calendar, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. Service date 03/17/2022 by CM/ECF. [3280112] [22-427]--[Edited 03/18/2022 by RW] [Entered: 03/17/2022 05:59 PM] |
| Filing 35 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellee Vetter Pharma International GMBH, FILED. Service date 03/16/2022 by CM/ECF.[3279195] [22-427] [Entered: 03/16/2022 04:17 PM] |
| Filing 34 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellee Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC, FILED. Service date 03/16/2022 by CM/ECF.[3278989] [22-427] [Entered: 03/16/2022 02:27 PM] |
| Filing 33 ATTORNEY, Benjamin Bradshaw for Novartis Technology LLC, Novartis Pharmaceuticals Corporation, and Novartis Pharma AG, in case 22-427, [ # 32 ], ADDED.[3278776] [22-427] [Entered: 03/16/2022 11:44 AM] |
| Filing 32 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC, FILED. Service date 03/16/2022 by CM/ECF. [3278754] [22-427] [Entered: 03/16/2022 11:26 AM] |
| Filing 31 ATTORNEY, Ian Simmons, [ # 30 ], in place of attorney George R. McGuire, SUBSTITUTED.[3278732] [22-427] [Entered: 03/16/2022 11:13 AM] |
| Filing 30 NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL, on behalf of Appellee Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC, FILED. Service date 03/16/2022 by CM/ECF. [3278719] [22-427] [Entered: 03/16/2022 10:56 AM] |
| Filing 29 LOCAL RULE 31.2 NOTICE, placing this appeal on the Court's Expedited Calendar, setting appellant's brief due date as 04/20/2022, appellee's brief due date as 05/25/2022,TRANSMITTED.[3278598] [22-427] [Entered: 03/16/2022 09:21 AM] |
| Filing 28 ATTORNEY, Julianne Marie Hartzell for Vetter Pharma International GMBH, in case 22-427, [ # 22 ], ADDED.[3278593] [22-427] [Entered: 03/16/2022 09:18 AM] |
| Filing 27 ATTORNEY, Benjamin T. Horton for Vetter Pharma International GMBH, in case 22-427, [ # 24 ], ADDED.[3278589] [22-427] [Entered: 03/16/2022 09:16 AM] |
| Filing 26 CURED DEFECTIVE NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, [ # 24 ], on behalf of Appellee Vetter Pharma International GMBH, FILED.[3278588] [22-427] [Entered: 03/16/2022 09:15 AM] |
| Filing 25 DEFECTIVE DOCUMENT, Notice of Appearance as Substitute Counsel, [20], on behalf of Appellee Vetter Pharma International GMBH, FILED.[3278575] [22-427] [Entered: 03/16/2022 09:09 AM] |
| Filing 24 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Vetter Pharma International GMBH, FILED. Service date 03/15/2022 by CM/ECF. [3278489] [22-427] [Entered: 03/15/2022 05:17 PM] |
| Filing 22 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Vetter Pharma International GMBH, FILED. Service date 03/15/2022 by CM/ECF, email. [3278329] [22-427] [Entered: 03/15/2022 03:18 PM] |
| Filing 20 NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL, on behalf of Appellee Vetter Pharma International GMBH, FILED. Service date 03/15/2022 by CM/ECF. [3278287] [22-427] [Entered: 03/15/2022 02:58 PM] |
| Filing 17 NEW CASE MANAGER, Ronald Willoughby, ASSIGNED.[3277846] [22-427] [Entered: 03/15/2022 09:52 AM] |
| Filing 11 LR 31.2 SCHEDULING NOTIFICATION, on behalf of Appellant Regeneron Pharmaceuticals, Inc., informing Court of proposed due date 06/10/2022, RECEIVED. Service date 03/11/2022 by CM/ECF.[3276755] [22-427] [Entered: 03/11/2022 04:10 PM] |
| Filing 10 FORM D, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. Service date 03/11/2022 by CM/ECF.[3276749] [22-427] [Entered: 03/11/2022 04:07 PM] |
| Filing 9 FORM C, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. Service date 03/11/2022 by CM/ECF.[3276746] [22-427] [Entered: 03/11/2022 04:05 PM] |
| Filing 8 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. Service date 03/10/2022 by CM/ECF.[3275894] [22-427] [Entered: 03/10/2022 04:02 PM] |
| Filing 7 ATTORNEY, Adam Banks for Appellant Regeneron Pharmaceuticals, Inc., in case 22-427, [ # 6 ], ADDED.[3275860] [22-427] [Entered: 03/10/2022 03:43 PM] |
| Filing 6 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. Service date 03/10/2022 by CM/ECF. [3275550] [22-427] [Entered: 03/10/2022 12:03 PM] |
| Filing 5 ELECTRONIC INDEX, in lieu of record, FILED.[3270958] [22-427] [Entered: 03/03/2022 11:13 AM] |
| Filing 4 DISTRICT COURT JUDGMENT, dated 01/31/2022, RECEIVED.[3270956] [22-427] [Entered: 03/03/2022 11:12 AM] |
| Filing 3 DISTRICT COURT ORDER, dated 01/31/2022, RECEIVED.[3270955] [22-427] [Entered: 03/03/2022 11:12 AM] |
| Filing 2 PAYMENT OF DOCKETING FEE, on behalf of Appellant Regeneron Pharmaceuticals, Inc., district court receipt # ANYNDC-5817402, FILED.[3270953] [22-427] [Entered: 03/03/2022 11:11 AM] |
| Filing 1 NOTICE OF CIVIL APPEAL, with district court docket, on behalf of Appellant Regeneron Pharmaceuticals, Inc., FILED. [3270943] [22-427] [Entered: 03/03/2022 11:08 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
